157 related articles for article (PubMed ID: 21129342)
1. Analysis: high-tech diabetes technology and the myth of clinical "plug and play".
Weinzimer SA
J Diabetes Sci Technol; 2010 Nov; 4(6):1465-7. PubMed ID: 21129342
[TBL] [Abstract][Full Text] [Related]
2. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.
Davey RJ; Jones TW; Fournier PA
J Diabetes Sci Technol; 2010 Nov; 4(6):1457-64. PubMed ID: 21129341
[TBL] [Abstract][Full Text] [Related]
3. Relationships among different glycemic variability indices obtained by continuous glucose monitoring.
Saisho Y; Tanaka C; Tanaka K; Roberts R; Abe T; Tanaka M; Meguro S; Irie J; Kawai T; Itoh H
Prim Care Diabetes; 2015 Aug; 9(4):290-6. PubMed ID: 25456706
[TBL] [Abstract][Full Text] [Related]
4. Simple Post-Processing of Continuous Glucose Monitoring Measurements Improves Endpoints in Clinical Trials.
Jensen MH; Dethlefsen C; Hejlesen O; Vestergaard P
J Diabetes Sci Technol; 2020 Nov; 14(6):1074-1078. PubMed ID: 31096765
[TBL] [Abstract][Full Text] [Related]
5. Effect of insulin therapy and dietary adjustments on safety and performance during simulated soccer tests in people with type 1 diabetes: study protocol for a randomized controlled trial.
Calvo-Marín J; Torrealba-Acosta G; Campbell M; Gaboury J; Ali A; Chen-Ku CH
Trials; 2017 Jul; 18(1):338. PubMed ID: 28728559
[TBL] [Abstract][Full Text] [Related]
6. The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trial.
Hermanns N; Schumann B; Kulzer B; Haak T
J Diabetes Sci Technol; 2014 May; 8(3):516-22. PubMed ID: 24876615
[TBL] [Abstract][Full Text] [Related]
7. Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study.
Campos-Náñez E; Breton MD
J Diabetes Sci Technol; 2017 Nov; 11(6):1196-1206. PubMed ID: 28560900
[TBL] [Abstract][Full Text] [Related]
8. A 5-Step Approach Protocol Using CareLink Therapy Software in Type 1 Diabetes Patients.
Petrovski G; Zivkovic M
J Diabetes Sci Technol; 2017 Nov; 11(6):1277. PubMed ID: 28879783
[No Abstract] [Full Text] [Related]
9. Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus.
Snogdal LS; Folkestad L; Elsborg R; Remvig LS; Beck-Nielsen H; Thorsteinsson B; Jennum P; Gjerstad M; Juhl CB
Diabetes Res Clin Pract; 2012 Oct; 98(1):91-7. PubMed ID: 22809714
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose monitors: use of waveform versus glycemic values in the improvements of glucose control, quality of life, and fear of hypoglycemia.
Walker TC; Yucha CB
J Diabetes Sci Technol; 2014 May; 8(3):488-93. PubMed ID: 24876611
[TBL] [Abstract][Full Text] [Related]
11. Clinically relevant hypoglycemia prediction metrics for event mitigation.
Harvey RA; Dassau E; Zisser HC; Bevier W; Seborg DE; Jovanovič L; Doyle FJ
Diabetes Technol Ther; 2012 Aug; 14(8):719-27. PubMed ID: 22690875
[TBL] [Abstract][Full Text] [Related]
12. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
14. Continuous glucose monitoring in youth with type 1 diabetes.
Wadwa RP; Fiallo-Scharer R; Vanderwel B; Messer LH; Cobry E; Chase HP
Diabetes Technol Ther; 2009 Jun; 11 Suppl 1():S83-91. PubMed ID: 19469682
[TBL] [Abstract][Full Text] [Related]
15. Clinical requirements for closed-loop control systems.
Clarke WL; Renard E
J Diabetes Sci Technol; 2012 Mar; 6(2):444-52. PubMed ID: 22538159
[TBL] [Abstract][Full Text] [Related]
16. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
[TBL] [Abstract][Full Text] [Related]
17. Glycemic Tracking Before and After Insulin Pump Initiation.
Johnson A; Hill NE; Godsland I; Oliver NS
J Diabetes Sci Technol; 2020 Sep; 14(5):970-971. PubMed ID: 32146846
[No Abstract] [Full Text] [Related]
18. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
[No Abstract] [Full Text] [Related]
19. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
20. The landmark JDRF continuous glucose monitoring randomized trials: a look back at the accumulated evidence.
Ruedy KJ; Tamborlane WV;
J Cardiovasc Transl Res; 2012 Aug; 5(4):380-7. PubMed ID: 22538483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
